Stay informed with the latest updates for the inheritable blood disorders community.

          Industry
          UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site
          UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site
          Industry
          BioMarin Reports Continued Progress in Clinical Trial for Hemophilia A Gene Therapy
          BioMarin Reports Continued Progress in Clinical Trial for…
          NBDF & Community
          Statement from COTT on the Hemophilia Memorial
          Choose the Inscription on the Hemophilia Memorial
          Choose the Inscription on the Hemophilia Memorial
          Industry
          Octapharma USA Funds National Camp Exchange for Bleeding Disorders Camps
          Octapharma USA Funds National Camp Exchange for Bleeding Disorders Camps
          Medical
          Updated Infusion Log Module Now Available Through Partners
          Updated Infusion Log Module Now Available Through Partners
          Industry
          Alnylam and Sanofi Report Positive Trial Updates for Fitusiran
          Alnylam and Sanofi Report Positive Trial Updates for Fitusiran
          Industry
          Shire Submits IND Application for Hemophilia A Gene Therapy Candidate
          Shire Submits IND Application for Hemophilia A Gene Therapy Candidate
          Industry
          Genentech Patient Foundation Responds to NHF-HFA Letter
          Genentech Announces Progress in Two Phase III Emicizumab Studies
          Advocacy & Legislative
          It's Not Too Late: Take Action on Tax Reform
          The Senate Bill (BCRA) Will Hurt the Bleeding Disorders Community
          NBDF & Community
          Green Park Collaborative, National Hemophilia Foundation, McMaster University, Announce Launch of CoreHEM Project
          Green Park Collaborative, National…
          Medical
          Study Yields Important Findings on the Functions of von Willebrand Factor
          Partners Relaunches Module on the Fundamentals…
          Industry
          FDA Accepts License Application and Grants Priority Review for Emicizumab
          FDA Approves Biologics License Application for Novo Nordisk’s…
          Industry
          Investigational Therapy for Hemophilia A Comes up Short in Trial
          Investigational Therapy for Hemophilia A Comes up Short in Trial
          Advocacy & Legislative
          A Million Dollar Patient in Perspective
          A Million Dollar Patient in Perspective